MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Ten Largest Investments

RNS
RNS Number : 0179F
JPMorgan Elect PLC
11 November 2020
 

JPMORGAN ELECT PLC  (the 'Company')


Legal Entity Identifier: 549300FIUYKKL39ILD07


THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 October 2020


Managed Growth portfolio


JPMorgan American Inv Trust

12.1%

JPM UK Equity Plus C

7.5%

JPMorgan US Equity All Capital C

7.4%

Finsbury Growth & Income

7.3%

JPMorgan Claverhouse Inv Trust

7.0%

JPMorgan UK Dynamic C

6.0%

JPMorgan US Select Equity C

5.6%

Murray Income Trust

3.7%

The Mercantile Inv Trust

3.1%

JPMorgan European Inv Trust (Growth)

2.8%

Total

62.5%

Managed Income portfolio


AstraZeneca

5.9%

Royal Dutch Shell

4.3%

Rio Tinto

4.1%

GlaxoSmithKline

3.9%

British American Tobacco

3.3%

Unilever

3.2%

Computacenter

2.7%

BP

2.6%

Phoenix Group

2.3%

OneSavings Bank

2.3%

Total

34.7%

* Based on invested portfolio


Name of contact and telephone number for queries:


Paul Ainger 0044 207 742 6524


Name of authorised company official responsible for making this notification:


Priyanka Vijay Anand 0044 203 493 1504 - Company Secretary


Date: 11 November 2020




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUKKDBQNBDDADD